The Effect of Plasma Triglyceride-Lowering Therapy on the Evolution of Organ Function in Early Hypertriglyceridemia-Induced Acute Pancreatitis Patients With Worrisome Features (PERFORM Study): Rationale and Design of a Multicenter, Prospective, Observational, Cohort Study

The Effect of Plasma Triglyceride-Lowering Therapy on the Evolution of Organ Function in Early Hypertriglyceridemia-Induced Acute Pancreatitis Patients With Worrisome Features (PERFORM Study): Rationale and Design of a Multicenter, Prospective, Observational, Cohort Study

Background: Acute pancreatitis (AP) is a potentially life-threatening inflammatory disease with multiple etiologies. The prevalence of hypertriglyceridemia-induced acute pancreatitis (HTG-AP) has been increasing in recent years. It is reported that early triglyceride (TG) levels were associated with...

Full description

Bibliographic Details
Main Authors: Longxiang Cao, Jing Zhou, Mingzhi Chen, Tao Chen, Man Liu, Wenjian Mao, Jiyan Lin, Donghuang Hong, Weijie Yao, Yi Sun, Kaixiu Qin, Feng Guo, Yun Zhou, Qinghai Jiao, Yingjie Chen, Gang Li, Bo Ye, Lu Ke, Zhihui Tong, Yuxiu Liu, Weiqin Li, Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG)
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Medicine
Subjects:
acute pancreatitis (AP)
hypertriglyceridemia (HTG)
TG-lowering therapy
organ failure free day
cohort study
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.756337/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.756337/full

Similar Items